首页 | 本学科首页   官方微博 | 高级检索  
     

冠心病患者冠状动脉介入治疗两种路径的比较
引用本文:祝鹏,谢静,任晖,刘胜强,屈兰燕,郑时康,王甲文. 冠心病患者冠状动脉介入治疗两种路径的比较[J]. 心脏杂志, 2013, 25(2): 194-196
作者姓名:祝鹏  谢静  任晖  刘胜强  屈兰燕  郑时康  王甲文
作者单位:(安康市中心医院心内科,陕西 安康725000)
摘    要:目的:比较冠心病患者冠状动脉介入治疗两种路径,以说明经桡动脉路径的优越性。方法: 选择行经皮冠状动脉介入治疗的423例冠心病患者,按采用的路径分为经桡动脉路径组(桡动脉组,213例)和经股动脉路径组(股动脉组,210例),分析两组间首次穿刺置管成功率、手术成功率、平均住院日及术后并发症的发生率。结果: 两组间首次穿刺置管成功率、手术成功率比较无显著差异。桡动脉组平均住院日、局部血肿、尿潴留、失眠、烦躁及并发症的总发生率均显著低于股动脉组,两组间比较有显著性差异(P<0.05)。结论: 经桡动脉路径行经皮冠状动脉介入治疗安全可行,可以作为首选路径。

关 键 词:冠状动脉疾病   经皮冠状动脉介入治疗术   并发症   经桡动脉介入
收稿时间:2012-11-12

Comparism study on percutaneous coronary intervention procedure of CAD patients through two defferent artery accesses
ZHU Peng,XIE Jing,REN Hui,LIU Sheng-qiang,QU Lan-yan,ZHENG Shi-kang,WANG Jia-wen. Comparism study on percutaneous coronary intervention procedure of CAD patients through two defferent artery accesses[J]. Chinese Heart Journal, 2013, 25(2): 194-196
Authors:ZHU Peng  XIE Jing  REN Hui  LIU Sheng-qiang  QU Lan-yan  ZHENG Shi-kang  WANG Jia-wen
Affiliation:(Department of Cardiology,Ankang City Central Hospital,Ankang 725000,Shaanxi,China)
Abstract:AIM:To explore the advantages of percutaneous coronary intervention (PCI) through transradial artery access. METHODS: A total of 423 patients undergoing percutaneous coronary intervention treatment were divided into two groups: patient group of 213 patients with PCI through transradial artery access and control group of 210 patients with PCI through transfemoral artery. The rate of one-time successful catheterization, success rate of PCI, mean hospital stay and incidence rates of postoperative complications were analyzed and compared. RESULTS: The incidence rate of postoperative complications in case group was much lower than in control group (P<0.05). CONCLUSION: Percutaneous coronary intervention treatment through transradial artery access is safe and feasible and should be the first choice approach.
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《心脏杂志》浏览原始摘要信息
点击此处可从《心脏杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号